Inflammation-induced glycolytic switch controls suppressivity of mesenchymal stem cells via STAT1 glycosylation

Regina Jitschin(Friedrich-Alexander-Universität Erlangen-Nürnberg), Dimitrios Mougiakakos(Otto-von-Guericke-Universität Magdeburg), Soeren Lukassen(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Arif B. Ekici(University Medical Center Groningen), Heiko Bruns(Friedrich-Alexander-Universität Erlangen-Nürnberg), Romy Loschinski(Otto-von-Guericke-Universität Magdeburg), Andréas Mackensen(University Medical Center Freiburg), Martin Böttcher(Otto-von-Guericke-Universität Magdeburg), André Reis(Universitätsklinikum Erlangen), Domenica Saul(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Leukemia
January 24, 2019
10.1038/s41375-018-0376-6
Cited by 113

Related Papers

<scp>SARS</scp> ‐CoV‐2 receptor <scp>ACE</scp> 2 and <scp>TMPRSS</scp> 2 are primarily expressed in bronchial transient secretory cells
|The EMBO Journal|2020|1k
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
|PLoS ONE|2015|906
Genome-wide, large-scale production of mutant mice by ENU mutagenesis
|Nature Genetics|2000|675
Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes
|Nature Genetics|2010|509
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
|The Lancet Oncology|2015|402